Tag Archives: Mylan

Pfizer Japan drawn into valsartan recall after finding API from Mylan is tainted

The global recall of valsartan has now extended to Pfizer and to Japan, via Mylan and India. According to a translated copy of its announcement, Pfizer’s Tokyo-based Japanese subsidiary said it is recalling from the country five lots of its blood pressure combo drug Amubaro because its API contains impurities that are probable carcinogens. The recall began… Read More »

Mylan to recall all batches of blood pressure medicine valsartan in U.S.

(Reuters) – Mylan NV said on Tuesday it is expanding a nationwide voluntary recall of its blood pressure medicine valsartan to include all lots, two weeks after it recalled select batches. The drugmaker said it was recalling 104 additional lots “out of an abundance of caution” after the valsartan-containing products were found to contain traces… Read More »